These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1358 related articles for article (PubMed ID: 21752789)

  • 61. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.
    Arai T; Hasegawa M; Akiyama H; Ikeda K; Nonaka T; Mori H; Mann D; Tsuchiya K; Yoshida M; Hashizume Y; Oda T
    Biochem Biophys Res Commun; 2006 Dec; 351(3):602-11. PubMed ID: 17084815
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Nuclear TAR DNA binding protein 43 expression in spinal cord neurons correlates with the clinical course in amyotrophic lateral sclerosis.
    Sumi H; Kato S; Mochimaru Y; Fujimura H; Etoh M; Sakoda S
    J Neuropathol Exp Neurol; 2009 Jan; 68(1):37-47. PubMed ID: 19104447
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Genetic analysis of matrin 3 gene in French amyotrophic lateral sclerosis patients and frontotemporal lobar degeneration with amyotrophic lateral sclerosis patients.
    Millecamps S; De Septenville A; Teyssou E; Daniau M; Camuzat A; Albert M; LeGuern E; Galimberti D; ; Brice A; Marie Y; Le Ber I
    Neurobiol Aging; 2014 Dec; 35(12):2882.e13-2882.e15. PubMed ID: 25158920
    [TBL] [Abstract][Full Text] [Related]  

  • 64. TDP-43 mutations causing amyotrophic lateral sclerosis are associated with altered expression of RNA-binding protein hnRNP K and affect the Nrf2 antioxidant pathway.
    Moujalled D; Grubman A; Acevedo K; Yang S; Ke YD; Moujalled DM; Duncan C; Caragounis A; Perera ND; Turner BJ; Prudencio M; Petrucelli L; Blair I; Ittner LM; Crouch PJ; Liddell JR; White AR
    Hum Mol Genet; 2017 May; 26(9):1732-1746. PubMed ID: 28334913
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Stress granules in neurodegeneration--lessons learnt from TAR DNA binding protein of 43 kDa and fused in sarcoma.
    Bentmann E; Haass C; Dormann D
    FEBS J; 2013 Sep; 280(18):4348-70. PubMed ID: 23587065
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Gain and loss of function of ALS-related mutations of TARDBP (TDP-43) cause motor deficits in vivo.
    Kabashi E; Lin L; Tradewell ML; Dion PA; Bercier V; Bourgouin P; Rochefort D; Bel Hadj S; Durham HD; Vande Velde C; Rouleau GA; Drapeau P
    Hum Mol Genet; 2010 Feb; 19(4):671-83. PubMed ID: 19959528
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Ultrastructure of ubiquitin-positive, TDP-43-negative neuronal inclusions in cerebral cortex of C9ORF72-linked frontotemporal lobar degeneration/amyotrophic lateral sclerosis.
    Lin W; Dickson DW
    Neuropathology; 2012 Dec; 32(6):679-81. PubMed ID: 22394026
    [No Abstract]   [Full Text] [Related]  

  • 68. TDP-43 proteinopathy: the neuropathology underlying major forms of sporadic and familial frontotemporal lobar degeneration and motor neuron disease.
    Kwong LK; Neumann M; Sampathu DM; Lee VM; Trojanowski JQ
    Acta Neuropathol; 2007 Jul; 114(1):63-70. PubMed ID: 17492294
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Mislocated FUS is sufficient for gain-of-toxic-function amyotrophic lateral sclerosis phenotypes in mice.
    Shiihashi G; Ito D; Yagi T; Nihei Y; Ebine T; Suzuki N
    Brain; 2016 Sep; 139(Pt 9):2380-94. PubMed ID: 27368346
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cognitive decline typical of frontotemporal lobar degeneration in transgenic mice expressing the 25-kDa C-terminal fragment of TDP-43.
    Caccamo A; Majumder S; Oddo S
    Am J Pathol; 2012 Jan; 180(1):293-302. PubMed ID: 22067910
    [TBL] [Abstract][Full Text] [Related]  

  • 71. ALS pathogenesis: recent insights from genetics and mouse models.
    Swarup V; Julien JP
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):363-9. PubMed ID: 20728492
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Inclusions in frontotemporal lobar degeneration with TDP-43 proteinopathy (FTLD-TDP) and amyotrophic lateral sclerosis (ALS), but not FTLD with FUS proteinopathy (FTLD-FUS), have properties of amyloid.
    Bigio EH; Wu JY; Deng HX; Bit-Ivan EN; Mao Q; Ganti R; Peterson M; Siddique N; Geula C; Siddique T; Mesulam M
    Acta Neuropathol; 2013 Mar; 125(3):463-5. PubMed ID: 23378033
    [No Abstract]   [Full Text] [Related]  

  • 73. The neuropathology of FTD associated With ALS.
    Mackenzie IR
    Alzheimer Dis Assoc Disord; 2007; 21(4):S44-9. PubMed ID: 18090423
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Human midsized neurofilament subunit induces motor neuron disease in transgenic mice.
    Gama Sosa MA; Friedrich VL; DeGasperi R; Kelley K; Wen PH; Senturk E; Lazzarini RA; Elder GA
    Exp Neurol; 2003 Nov; 184(1):408-19. PubMed ID: 14637110
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A neurotoxic peripherin splice variant in a mouse model of ALS.
    Robertson J; Doroudchi MM; Nguyen MD; Durham HD; Strong MJ; Shaw G; Julien JP; Mushynski WE
    J Cell Biol; 2003 Mar; 160(6):939-49. PubMed ID: 12642616
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Amyotrophic lateral sclerosis features predict TDP-43 pathology in frontotemporal lobar degeneration.
    Long Z; Irish M; Hodges JR; Halliday G; Piguet O; Burrell JR
    Neurobiol Aging; 2021 Nov; 107():11-20. PubMed ID: 34371283
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Phosphorylated and cleaved TDP-43 in ALS, FTLD and other neurodegenerative disorders and in cellular models of TDP-43 proteinopathy.
    Arai T; Hasegawa M; Nonoka T; Kametani F; Yamashita M; Hosokawa M; Niizato K; Tsuchiya K; Kobayashi Z; Ikeda K; Yoshida M; Onaya M; Fujishiro H; Akiyama H
    Neuropathology; 2010 Apr; 30(2):170-81. PubMed ID: 20102522
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A new subtype of frontotemporal lobar degeneration with FUS pathology.
    Neumann M; Rademakers R; Roeber S; Baker M; Kretzschmar HA; Mackenzie IR
    Brain; 2009 Nov; 132(Pt 11):2922-31. PubMed ID: 19674978
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The basis of clinicopathological heterogeneity in TDP-43 proteinopathy.
    Kawakami I; Arai T; Hasegawa M
    Acta Neuropathol; 2019 Nov; 138(5):751-770. PubMed ID: 31555895
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Expression of peripherin in ubiquinated inclusions of amyotrophic lateral sclerosis.
    He CZ; Hays AP
    J Neurol Sci; 2004 Jan; 217(1):47-54. PubMed ID: 14675609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 68.